SCHEMBL25857088

SCHEMBL25857088

CCn1nc(C2CCC(=O)NC2=O)c2cccc(C)c21

nearest known ligand 0.59

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 20/20 0.59
DDB1 Q16531 19/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25864328 0.89 CRBN (0.57) CRBNDDB1
SCHEMBL25864329 0.87 CRBN (0.55) CRBNDDB1
SCHEMBL25857220 0.86 CRBN (0.57) CRBNDDB1
SCHEMBL25566760 0.85 DDB1 (0.77) CRBNDDB1
SCHEMBL25027088 0.85 DDB1 (0.77) CRBNDDB1
SCHEMBL25858346 0.82 CRBN (0.72) CRBNDDB1
SCHEMBL25858419 0.80 DDB1 (0.57) CRBNDDB1
SCHEMBL25864330 0.79 DDB1 (0.56) CRBNDDB1
SCHEMBL25864333 0.78 DDB1 (0.55) CRBNDDB1
SCHEMBL29342637 0.78 CRBN (0.73) CRBNDDB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023131167-A1 COMPOUND FOR INHIBITING AND DEGRADING IRAK4, AND PHARMACEUTICAL COMPOSITION AND PHARMACEUTICAL APPLICATION THEREOF 海思科医药集团股份有限公司 2023-07-13 WO disclosed